Literature DB >> 25747111

Comparison of three-dimensional proximal isovelocity surface area to cardiac magnetic resonance imaging for quantifying mitral regurgitation.

Nicolas Brugger1, Kerstin Wustmann2, Michael Hürzeler2, Andreas Wahl2, Stefano F de Marchi2, Hélène Steck2, Fabian Zürcher2, Christian Seiler2.   

Abstract

The aim of our study was to evaluate 3-dimensional (3D) color Doppler proximal isovelocity surface area (PISA) as a tool for quantitative assessment of mitral regurgitation (MR) against in vitro and in vivo reference methods. A customized 3D PISA software was validated in vitro against a flowmeter MR phantom. Sixty consecutive patients, with ≥mild MR of any cause, were recruited and the regurgitant volume (RVol) was measured by 2D PISA, 3D peak PISA, and 3D integrated PISA, using transthoracic (TTE) and transesophageal echocardiography (TEE). Cardiac magnetic resonance imaging (CMR) was used as reference method. Flowmeter RVol was associated with 3D integrated PISA as follows: y = 0.64x + 4.7, r(2) = 0.97, p <0.0001 for TEE and y = 0.88x + 4.07, r(2) = 0.96, p <0.0001 for TTE. The bias and limit of agreement in the Bland-Altman analysis were 6.8 ml [-3.5 to 17.1] for TEE and -0.059 ml [-6.2 to 6.1] for TTE. In vivo, TEE-derived 3D integrated PISA was the most accurate method for MR quantification compared to CMR: r(2) = 0.76, y = 0.95x - 3.95, p <0.0001; 5.1 ml (-14.7 to 26.5). It was superior to TEE 3D peak PISA (r(2) = 0.67, y = 1.00x + 6.20, p <0.0001; -6.3 ml [-33.4 to 21.0]), TEE 2D PISA (r(2) = 0.54, y = 0.76x + 0.18, p <0.0001; 8.4 ml [-20.4 to 37.2]), and TTE-derived measurements. It was also most accurate by receiver operating characteristic analysis (area under the curve 0.99) for the detection of severe MR, RVol cutoff = 48 ml, sensibility 100%, and specificity 96%. RVol and the cutoff to define severe MR were underestimated using the most accurate method. In conclusion, quantitative 3D color Doppler echocardiography of the PISA permits a more accurate MR assessment than conventional techniques and, consequently, should enable an optimized management of patients suffering from MR.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25747111     DOI: 10.1016/j.amjcard.2015.01.550

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Recommendation of Early Surgery in Primary Mitral Regurgitation: Pros and Cons.

Authors:  Levent Cerit; Vitor Emer Egypto Rosa; Flávio Tarasoutchi
Journal:  Arq Bras Cardiol       Date:  2017-01       Impact factor: 2.000

2.  Quantification of mitral valve regurgitation by 2D and 3D echocardiography compared with cardiac magnetic resonance a systematic review and meta-analysis.

Authors:  Victor Sköldborg; Per Lav Madsen; Morten Dalsgaard; Jawdat Abdulla
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-29       Impact factor: 2.357

Review 3.  Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging.

Authors:  Pankaj Garg; Andrew J Swift; Liang Zhong; Carl-Johan Carlhäll; Tino Ebbers; Jos Westenberg; Michael D Hope; Chiara Bucciarelli-Ducci; Jeroen J Bax; Saul G Myerson
Journal:  Nat Rev Cardiol       Date:  2019-12-09       Impact factor: 32.419

Review 4.  Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions.

Authors:  Mirjam G Winkel; Nicolas Brugger; Omar K Khalique; Christoph Gräni; Adrian Huber; Thomas Pilgrim; Michael Billinger; Stephan Windecker; Rebecca T Hahn; Fabien Praz
Journal:  Front Cardiovasc Med       Date:  2020-05-05

Review 5.  Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?

Authors:  Zhang Xiling; Thomas Puehler; Lars Sondergaard; Derk Frank; Hatim Seoudy; Baland Mohammad; Oliver J Müller; Stephanie Sellers; David Meier; Janarthanan Sathananthan; Georg Lutter
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

6.  Clinical intra-cardiac 4D flow CMR: acquisition, analysis, and clinical applications.

Authors:  Ahmet Demirkiran; Pim van Ooij; Jos J M Westenberg; Mark B M Hofman; Hans C van Assen; Linda J Schoonmade; Usman Asim; Carmen P S Blanken; Aart J Nederveen; Albert C van Rossum; Marco J W Götte
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-01-24       Impact factor: 6.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.